Wells Fargo’s Pyxis Oncology PYXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.6M Buy
1,117,563
+1,117,278
+392,027% +$3.38M ﹤0.01% 3141
2026
Q2
$858 Hold
285
– – ﹤0.01% 6469
2026
Q1
$416 Sell
285
-2,000
-88% -$3.01K ﹤0.01% 6413
2025
Q4
$2.63K Buy
2,285
+2,000
+702% +$7.05K ﹤0.01% 6193
2025
Q3
$633 Sell
285
-414
-59% -$596 ﹤0.01% 6285
2025
Q2
$769 Sell
699
-29,191
-98% -$32.9K ﹤0.01% 6336
2025
Q1
$29.3K Buy
29,890
+941
+3% +$1.26K ﹤0.01% 5579
2024
Q4
$45.2K Buy
28,949
+4,724
+20% +$13.6K ﹤0.01% 5518
2024
Q3
$88.9K Buy
24,225
+2,183
+10% +$7.64K ﹤0.01% 5085
2024
Q2
$73K Buy
22,042
+21,208
+2,543% +$89.2K ﹤0.01% 5121
2024
Q1
$3.55K Sell
834
-1,697
-67% -$7.14K ﹤0.01% 5946
2023
Q4
$4.56K Buy
2,531
+23
+0.9% +$39 ﹤0.01% 5972
2023
Q3
$4.99K Buy
2,508
+38
+2% +$88 ﹤0.01% 5956
2023
Q2
$6.32K Buy
2,470
+307
+14% +$974 ﹤0.01% 6035
2023
Q1
$8.67K Buy
2,163
+2,003
+1,252% +$4K ﹤0.01% 5906
2022
Q4
$214 Buy
160
+14
+10% +$21 ﹤0.01% 6601
2022
Q3
$0 Buy
146
+76
+109% +$199 ﹤0.01% 7212
2022
Q2
$0 Sell
70
-5,245
-99% -$14K ﹤0.01% 7334
2022
Q1
$21K Sell
5,315
-6,099
-53% -$44.6K ﹤0.01% 5993
2021
Q4
$125K Buy
+11,414
New +$131K ﹤0.01% 5517

Other funds holding PYXS

Wells Fargo's PYXS Position: Q3 2026 in Review

Wells Fargo increased its Pyxis Oncology (PYXS) stake by 392,027% in Q3 2026, buying an estimated $3.38M and bringing the position to 1,117,563 shares worth $2.6M. The position accounts for ﹤0.01% of the portfolio, ranked #3141.

Wells Fargo first reported a position in PYXS in Q4 2021 and has held it in 20 quarters since. 101 funds tracked by Wall St. Rank hold PYXS as of Q3 2026.

  • Wells Fargo held 1,117,563 shares of Pyxis Oncology worth $2.6M as of Q3 2026.
  • Wells Fargo bought 1,117,278 Pyxis Oncology shares in Q3 2026, an estimated $3.38M.
  • Pyxis Oncology made up ﹤0.01% of Wells Fargo's portfolio in Q3 2026, its #3141 holding.
  • Wells Fargo first reported a position in Pyxis Oncology in Q4 2021 and has held it in 20 quarters since.
  • 101 funds tracked by Wall St. Rank held Pyxis Oncology as of Q3 2026.

Based on Wells Fargo's 13F filing for Q3 2026, filed 16 Nov 2026.